Is crying actually good for you?
Dr. Katie Thorsness, a psychiatrist with Redleaf Center for Family Healing at Hennepin Healthcare, says crying is a multi-layered phenomenon. Reflex tears come from irritated eyes or cutting onions, while emotional tears come for many reasons.
"These tears are a signal of what emotion am I feeling? And what can I do with that and how can I feel that in this moment?" Thorsness said.
The tears themselves have a structure similar to saliva — composed of mucus, water and oil. And while babies don't develop tears until they're about 2 months old, the noise starts on day one.
"Their brains aren't developed enough to tell us, 'Mom, I am hungry, I do need my diaper changed,' but they do know crying is a signal," she said.
Thorsness says it's a way of communicating, flagging others that we need support, and a way the body takes care of itself.
"We actually release and flush out a stress hormone which helps us internally feel better, and during crying we also release endorphins or feel good hormones in our biology as well," she said. "So you absolutely can feel better after a good cry."
And there's no need to apologize for crying. Thorsness says crying is good for you and your health. As for when someone else is crying, she says it's important to acknowledge and just be there as they cry; words may not be necessary, just comfort.
But she says if it becomes excessive and gets in the way of your life, check in with your doctor.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
4 hours ago
- Yahoo
With UnitedHealth Under DOJ Investigation, Should You Buy, Sell, or Hold UNH Stock Now?
UnitedHealth Group (UNH) last week officially confirmed what Wall Street has suspected for months: The healthcare giant is facing both criminal and civil Department of Justice investigations into its Medicare billing practices. The announcement sent UNH stock lower by more than 3% last week, adding another layer of uncertainty to what has already been a tumultuous year for the nation's largest private insurer. More News from Barchart Morgan Stanley Says Nvidia Has 'Exceptional' Strength. Should You Buy NVDA Stock Here? 2 Growth Stocks Wall Street Predicts Will Soar 74% to 159% Dear MicroStrategy Stock Fans, Mark Your Calendars for July 31 Tired of missing midday reversals? The FREE Barchart Brief newsletter keeps you in the know. Sign up now! In a securities filing, UnitedHealth revealed it is cooperating with formal DOJ requests and has launched a third-party review of its business policies. The company maintains 'full confidence in its practices' and expects to complete the independent audit by the end of the third quarter. However, this confirmation marks a significant shift from previous denials of any DOJ investigation. UnitedHealth now faces what Mizuho analyst Ann Hynes calls a 'perfect storm.' UNH stock has plummeted over 45% this year following a cascade of setbacks including the abrupt departure of CEO Andrew Witty in May, suspended 2025 earnings guidance due to skyrocketing medical costs, and ongoing fallout from the December murder of CEO Brian Thompson. The DOJ investigations target the company's Medicare Advantage business, which generated $139 billion in revenue last year. Reports suggest that prosecutors are examining whether UnitedHealth inflated diagnoses to trigger higher Medicare payments and whether doctors felt pressured to submit claims for certain conditions that would boost reimbursements. Investment Outlook for UNH Stock: Cautiously Optimistic Despite the mounting challenges, several analysts maintain a measured outlook. Mizuho's Hynes believes investor concerns are overblown, noting 'the stock is trading like the government's going to kick them out of Medicare and Medicaid, and the likelihood of that is zero.' Hynes expects the situation to be resolved with a financial settlement and a corporate integrity agreement, a common outcome for such investigations. Plus, UnitedHealth's fundamentals remain strong despite current headwinds. It serves nearly 150 million people and has built an integrated healthcare ecosystem spanning insurance, medical services, and pharmacy benefits. Its scale advantages and market position in Medicare Advantage provide long-term defensive qualities. UNH stock also faces ongoing challenges with its Optum Health physician practice unit, where profits have collapsed due to changes in Medicare reimbursement. Recovery here is essential for the integrated care model that has driven UnitedHealth's competitive advantages. Is UNH Stock Undervalued? Analysts tracking UNH stock forecast adjusted earnings per share to narrow from $27.66 in 2024 to $18.07 in 2025. However, earnings are forecast to improve to $34.61 by 2029. UNH stock trades at a forward price-earnings multiple of 13.3x, which is reasonable. If it trades at 15x forward earnings, UNH stock should be priced around $510 in early 2029, indicating upside potential of almost 100% from current levels. Out of the 24 analysts covering UNH stock, 15 recommend 'Strong Buy,' two recommend 'Moderate Buy,' and seven recommend 'Hold.' The average target price for UNH stock is $354.42, 33% above the current price. For existing shareholders, this appears to be a 'Hold' situation. While near-term volatility is likely to continue, UnitedHealth's market position and the essential nature of healthcare services provide downside protection. The DOJ investigation, although serious, is unlikely to pose existential threats to the business. New investors may want to wait for more clarity on earnings guidance and investigation outcomes before establishing positions. However, long-term investors willing to weather current storms may find opportunity in the significant valuation compression already reflected in the stock price. On the date of publication, Aditya Raghunath did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. This article was originally published on
CBS News
4 hours ago
- CBS News
Mayo Clinic refused employee's COVID-19 vaccine exemption request, lawsuit says
A lawsuit filed by the U.S. Equal Employment Opportunity Commission on Thursday alleges the Mayo Clinic violated federal law when it refused a security guard's request to be exempt from getting the COVID-19 vaccine due to his religious beliefs. Mayo implemented a mandatory COVID-19 vaccination policy around Oct. 13, 2021, which required all of its employees to receive the vaccine by Dec. 3, 2021, unless they received a medical or religious exemption, according to the court document. Anyone who didn't follow the policy would be terminated. On Nov. 1, 2021, the security guard, who was not named in the lawsuit, submitted an accommodation form to the clinic requesting that he be exempt from the policy, stating "his religious observance or practice conflicted with the COVID-19 vaccine," the complaint said. According to the lawsuit, the form stated he is a member of an Assemblies of God Church, which believes the vaccine contained ingredients that "were inconsistent with his religious belief," and he could not "put those ingredients in his body." The employee also believed that if he were to die from the vaccine, it would be considered suicide and undermine God's faith. The security guard said he would be willing to wear a mask and take COVID-19 tests if he were granted an exemption to the policy. On Nov. 21, 2021, Mayo denied the request, stating the employee didn't meet the criteria for a religious exemption, the lawsuit said. The security guard submitted a reconsideration request the next day. Mayo denied the reconsideration request on Dec. 1 and said he must get the vaccine or else he would be fired. The clinic issued a final written warning to the security guard on Dec. 3, saying he would be terminated if he did not receive the vaccine by January 2022. The EEOC alleges Mayo violated Title VII of the Civil Rights Act, which prohibits companies from discriminating against employees based on religion. The federal agency is seeking monetary damages, though it's unclear how much. According to the lawsuit, the EEOC is also asking Mayo to implement policies and programs that "provide equal employment opportunities for religious persons." A spokesperson for Mayo Clinic said the company would not comment "due to pending litigation."
Yahoo
9 hours ago
- Yahoo
UnitedHealth Group appoints new CFO in wake of top leadership change
After a year that has seen its share price collapse by more than 50%, UnitedHealth Group (UNH) has swapped out its chief financial officer. Wayne DeVeydt will take over as CFO of UnitedHealth effective Sept. 2, according to securities filings. He replaces John Rex, who has been in the role since 2016. Shares of UnitedHealth dropped around .60% early Friday. The move, announced Thursday night, follows UnitedHealth founder and executive chairman Stephen Hemsley taking back the reins following CEO Andrew Witty's sudden departure in May. Rex will transition from CFO to strategic adviser to the CEO, a move that UnitedHealth said in filings was arranged in Rex's 2016 employment contract. "Given the downward revisions to estimates in the past six months, the return of CEO Stephen Hemsley, and the extensive management changes made across UNH, we appreciate the desire to make a change at CFO," JPMorgan analyst Lisa Gill wrote in a note. Read more: What is a healthcare FSA and how can it help you save on medical costs? DeVeydt is joining an insurance giant under pressure. In its earnings release this week, UnitedHealth reported its highest-ever medical loss ratio (MLR), at 89.4%, highlighting the company's cost pressures. MLR is the ratio of claims paid versus revenue from premiums received; the Affordable Care Act defines good management as a window between 80% and 85%. The company reported higher revenues than Wall Street expectations, $111.6 billion compared to estimates of $111.53 billion. UnitedHealth missed on earnings per share, reporting $4.08 compared to Street expectations of $4.59. The company had previously slashed its annual forecast in April after its medical care costs came in higher than expected, sending shares down by 22% in UnitedHealth's biggest drop in a single day since 1998. In May, UnitedHealth had contributed to 88% of the Dow's decline in the past year. UnitedHealth is also currently facing a criminal and civil investigation by the Department of Justice over potential fraudulent billing practices in its Medicare Advantage program. DeVeydt was most recently an operating partner at private equity giant Bain Capital and was previously executive chair of surgical operator Surgery Partners. CEO Hemsley said on an earnings call this week that over the past two months, the company has "made extensive management and operational changes" to align with its agenda of reform and performance. "Other such changes — to our leadership, to our businesses, our culture, approaches, and practices, and to our board, governance, and succession oversight, as appropriate, will continue to be made as we proceed through this period," he said. Jake Conley is a breaking news reporter covering US equities for Yahoo Finance. Follow him on X at @byjakeconley or email him at Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
